WCBD1 个月
Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for ...
NEWTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
Morningstar14 天
Auron Therapeutics Expands Leadership with Appointment of Glenn Goddard as Chief Financial ...
NEWTON, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and ...
The Business Journals1 个月
Biotech raises Series B to test cancer drug in the clinic
Kate Yen is the founder and CEO of Auron Therapeutics. From the Boston Business Journal. Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical ...